Cleavage of misfolded nuclear receptor corepressor confers resistance to unfolded protein response-induced apoptosis

Cancer Research

Volumn 66, Issue 20, 2006, Pages 9903-9912

  Ng, Angela Ping Ping ^a,c   Fong, Jek Howe ^a   Nin, Dawn Sijin ^a   Hirpara, Jayshree L ^a   Asou, Norio ^d   Chen, Chien Shing ^a,b   Pervaiz, Shazib ^a,c   Khan, Matiullah ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; GLYCOPROTEIN; HORMONE RECEPTOR; NUCLEAR PROTEIN; PROTEIN NUCLEAR HORMONE RECEPTOR COREPRESSOR; PROTEINASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; DOWN REGULATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN AGGREGATION; PROTEIN DEGRADATION; SPECTROMETRY; STRESS;

APOPTOSIS; CELL GROWTH PROCESSES; EDETIC ACID; ENDOPLASMIC RETICULUM; HL-60 CELLS; HUMANS; K562 CELLS; LEUKEMIA, PROMYELOCYTIC, ACUTE; METALLOENDOPEPTIDASES; NUCLEAR PROTEINS; PROTEASE INHIBITORS; PROTEIN FOLDING; REPRESSOR PROTEINS; SULFONES; U937 CELLS;

EID: 33750559637     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0002     Document Type: Article

References (37)

1. Pandolfi PP, Alcalay M, Fagioli M, et al. Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukaemia. EMBO J 1992;4:1397-407.
2. The HD, Chomienne C, Lannotte D, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 1990;34:558-68.
3. Kakizuka A, Miller WH, Umesono K, et al. Chromosomal translocation t(15:17) in human acute promyelocytic leukemia fuses RAR with a novel putative transcription factor PML. Cell 1991;66:663-75.
4. Warrell RP, Jr., Frankel SR, Miller WH, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991;324:1385-93.
5. Fenaux P, Chastang C, Chevret S, et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 1999;94:1192-2000.
6. Chomienne C, Fenaux P, Degos L. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J 1996;10:1025-30.
7. Khan MM, Nomura T, Kim H, et al. Role of PML and PML-RAR in Mad-mediated transcriptional repression. Mol Cell 2001;6:1233-43.
8. Khan MM, Nomura T, Chiba T, et al. The fusion on-protein PML-RAR induces endoplasmic reticulum associated degradation of N-CoR and ER stress. J Biol Chem 2004;279:11814-24.
9. Hörlein AJ, Näär AM, Heinzel T, et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor. Nature 1995;377:397-404.
10. Heinzel TRM, Lavinsky TM, Mullen M, et al. A complex containing N-CoR, mSin3, and histone deacetylase mediates transcriptional repression. Nature 1997;387:43-8.
11. Laherty CD, Yang WM, Sun JM, Davie JR, Seto K, Eisenman RN. Histone deacetylase associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 1997;89:349-56.
12. Laherty CD, Billin AN, Lavinsky RM, et al. SAP30, a component of the mSin3 corepressor complex involved in N-CoR-mediated repression by specific transcription factors. Mol Cell 1998;2:33-42.
13. Keeton EK, Brown M. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-α and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT. Mol Endocrinol 2005;19:1543-54.
14. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH, Evans RM. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 1998;391:811-4.
15. Grignani F, De Matteis S, Nervi C, et al. Fusion proteins of the retinoic acid receptor-α recruits histone deacetylase in promyelocytic leukaemia. Nature 1998;391:815-8.
16. Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S, Zelent A. Reduced retinoic acid sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARα underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 1998;91;2634-42.
17. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2003;14:121-41.
18. Yanjun M, Hendershot LM. The role of the unfolded protein response in tumor development: friend or foe? Nat Rev Cancer 2004;4:966-77.
19. Kaufman RJ. Orchestrating the unfolded protein responses in health and diseases. J Clin Invest 2002;110:1389-98.
20. Lee AH, Iwakoshi NN, Anderson KC, Glimcher LH. Proteasome inhibitors disrupt the unfolded protein responses in myeloma cells. Proc Natl Acad Sci U S A 2003;100:9946-51.
21. Lane AA, Ley TJ. Neutrophil elastase cleaves PML-RARα and is important for the development of acute promyelocytic leukemia in mice. Cell 2003;115:305-18.
22. Lane AA, Ley TJ. Neutrophil elastase is important for PML-retinoic acid receptor activities in early myeloid cells. Mol Cell Biol 2005;25:23-33.
23. Ferrucci PR, Grignani F, Pearson M, Fagioli M, Nicoletti I, Pellici PG. Cell death induction by the acute promyelocytic leukemia-specific PML-RAR fusion protein. Proc Natl Acad Sci U S A 1997;94:10901-6.
24. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR under control of cathepsin G regulatory sequences. Blood 1997;89:376-87.
25. He LZ, Tribioli C, Rivi R, et al. Acute leukemia promyelocytic features in PML-RAR transgenic mice. Proc Natl Acad Sci U S A 1997;94:5302-7.
26. Westervelt P, Lane AA, Pollock JL, et al. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RAR expression. Blood 2003;102:1857-65.
27. Kizaki M, Matsushita H, Takayama N, et al. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features. Blood 1996;88:1824-33.
28. Haze K, Yoshida H, Yanagi H, Yura T, Mori K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 1999;10:3787-99.
29. Marciniak SJ, Yun CY, Oyadomari S, et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 2004;18:3066-77.
30. Xue X, Piao J, Nakajima A, et al. TNFα induces the unfolded protein response (UPR) in a ROS-dependent fashion, and the UPR counteracts ROS accumulation by TNFα. J Biol Chem 2005;280:33917-25.
31. Abdullah KM, Udoh EA, Shewen PE, Mellors A. A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-sialoglycoproteins. Infect Immun 1992;60:56-62.
32. Otulakowski GL, Shewen PE, Udoh AE, Mellors A, Wilkie BN. Proteolysis of sialoglycoprotein by Pasteurella haemolytica cytotoxic culture supernatant. Infect Immun 1983;42:64-70.
33. Selkoe DJ. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med 2004;140:627-38.
34. Bruin EC, Meersma D, Wilde JD, et al. A serine protease is involved in the initiation of DNA damage-induced apoptosis. Cell Death Differ 2003;10:1204-12.
35. Okada T, Haze K, Nadanaka S, et al. A serine protease inhibitor prevents endoplasmic reticulum stress-induced cleavage but not transport of the membrane-bound transcription factor ATF6. J Biol Chem 2003;278:31024-32.
36. Bence N, Sampat R, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001;292:1552-5.
37. Jana NR, Zemskov EA, Wang G, Nukina N. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum Mol Genet 2001;10:1049-59.